Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023)

Bicycle Therapeutics (BCYC) has disclosed Construction in Progress for 2 consecutive years, with $400000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Construction in Progress changed N/A year-over-year to $400000.0, compared with a TTM value of $400000.0 through Jun 2023, changed N/A, and an annual FY2022 reading of $2.3 million, changed N/A over the prior year.
  • Construction in Progress was $400000.0 for Q2 2023 at Bicycle Therapeutics, down from $2.3 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $2.3 million in Q4 2022 and bottomed at $400000.0 in Q2 2023.